{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:15:38Z","timestamp":1793218538993,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["KRINGLE2 ANR-20-CE14-0009"],"award-info":[{"award-number":["KRINGLE2 ANR-20-CE14-0009"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jlr.2023.100426","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T20:43:58Z","timestamp":1692045838000},"page":"100426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["PCSK9 and the nervous system: a no-brainer?"],"prefix":"10.1016","volume":"64","author":[{"given":"Ali K.","family":"Jaafar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romuald","family":"Techer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e9vin","family":"Chemello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5632-0685","authenticated-orcid":false,"given":"Gilles","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9805-2196","authenticated-orcid":false,"given":"Steeve","family":"Bourane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2023.100426_bib1","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1073\/pnas.0335507100","article-title":"The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation","volume":"100","author":"Seidah","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2023.100426_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jlr.2023.100426_bib3","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2023.100426_bib4","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1073\/pnas.0501652102","article-title":"Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9","volume":"102","author":"Rashid","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2023.100426_bib5","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1194\/jlr.R026658","article-title":"The PCSK9 decade Thematic review series: new lipid and lipoprotein targets for the treatment of Cardiometabolic diseases","volume":"53","author":"Lambert","year":"2012","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100426_bib6","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI29383","article-title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice","volume":"116","author":"Lagace","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2023.100426_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.atherosclerosis.2006.08.039","article-title":"The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population","volume":"193","author":"Hooper","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2023.100426_bib8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1086\/507488","article-title":"Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote","volume":"79","author":"Zhao","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jlr.2023.100426_bib9","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2023.100426_bib10","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2023.100426_bib11","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2023.100426_bib12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s11883-022-01057-z","article-title":"Expanding biology of PCSK9: roles in atherosclerosis and beyond","volume":"24","author":"Seidah","year":"2022","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.jlr.2023.100426_bib13","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.22354","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration","volume":"48","author":"Zaid","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2023.100426_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","article-title":"Cholesterol metabolism in the brain","volume":"12","author":"Dietschy","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jlr.2023.100426_bib15","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100426_bib16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1471-4159.1995.64010424.x","article-title":"Lipid composition of neuronal cell bodies and neurites from cultured dorsal root ganglia","volume":"64","author":"Calderon","year":"1995","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jlr.2023.100426_bib17","doi-asserted-by":"crossref","first-page":"30766","DOI":"10.1074\/jbc.272.49.30766","article-title":"Role of lipoproteins in the delivery of lipids to axons during axonal regeneration\u2217","volume":"272","author":"de Chaves","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2023.100426_bib18","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.bbalip.2016.09.011","article-title":"Cholesterol 24-hydroxylase: brain cholesterol metabolism and beyond","volume":"1861","author":"Moutinho","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2023.100426_bib19","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","article-title":"CNS synaptogenesis promoted by glia-derived cholesterol","volume":"294","author":"Mauch","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jlr.2023.100426_bib20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1471-4159.1973.tb07519.x","article-title":"Myelination in rat brain: method of myelin isolation1","volume":"21","author":"Norton","year":"1973","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jlr.2023.100426_bib21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1471-4159.1973.tb07520.x","article-title":"Myelination in rat brain: changes in myelin composition during brain maturation1","volume":"21","author":"Norton","year":"1973","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jlr.2023.100426_bib22","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1126\/science.147.3662.1099","article-title":"Stability of the myelin membrane","volume":"147","author":"O\u2019brien","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.jlr.2023.100426_bib23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nn1426","article-title":"High cholesterol level is essential for myelin membrane growth","volume":"8","author":"Saher","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jlr.2023.100426_bib24","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/cells9040812","article-title":"Myelin fat facts: an overview of lipids and fatty acid metabolism","volume":"9","author":"Poitelon","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jlr.2023.100426_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1471-4159.1967.tb09532.x","article-title":"Lipid composition of myelin from the peripheral nervous system. Intradural spinal roots","volume":"14","author":"O\u2019Brien","year":"1967","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jlr.2023.100426_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1471-4159.1966.tb06794.x","article-title":"The lipid composition of purified bovine brain myelin","volume":"13","author":"Norton","year":"1966","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jlr.2023.100426_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0005-2736(68)90138-7","article-title":"The lipid composition of rat-liver plasma membranes","volume":"150","author":"Dod","year":"1968","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2023.100426_bib28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1194\/jlr.R009761","article-title":"Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models","volume":"52","author":"Chrast","year":"2011","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100426_bib29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10545-012-9509-7","article-title":"Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases","volume":"36","author":"Lamari","year":"2013","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.jlr.2023.100426_bib30","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1471-4159.2001.00598.x","article-title":"Neuronal differentiation is triggered by oleic acid synthesized and released by astrocytes","volume":"79","author":"Tabernero","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jlr.2023.100426_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.plefa.2012.05.008","article-title":"n-3 Polyunsaturated fatty acids in animal models with neuroinflammation","volume":"88","author":"Orr","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.jlr.2023.100426_bib32","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1101\/gad.1116203","article-title":"Local regulation of fat metabolism in peripheral nerves","volume":"17","author":"Verheijen","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.jlr.2023.100426_bib33","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1172\/JCI105650","article-title":"Brain metabolism during fasting","volume":"46","author":"Owen","year":"1967","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2023.100426_bib34","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1194\/jlr.R006338","article-title":"Genetic connections between neurological disorders and cholesterol metabolism","volume":"51","author":"Bj\u00f6rkhem","year":"2010","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100426_bib35","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.csbj.2020.06.001","article-title":"Plasma lipidomic biomarker analysis reveals distinct lipid changes in vascular dementia","volume":"18","author":"Liu","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.jlr.2023.100426_bib36","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archneur.57.4.520","article-title":"Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis","volume":"57","author":"Verrips","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jlr.2023.100426_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00234-003-1110-1","article-title":"MRI and 1H MRS findings in Smith-lemli-opitz syndrome","volume":"46","author":"Caruso","year":"2004","journal-title":"Neuroradiology"},{"key":"10.1016\/j.jlr.2023.100426_bib38","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1073\/pnas.051630598","article-title":"An orchestrated gene expression component of neuronal programmed cell death revealed by cDNA array analysis","volume":"98","author":"Chiang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2023.100426_bib39","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00018-012-0977-6","article-title":"PCSK9 regulates neuronal apoptosis by adjusting ApoER2 levels and signaling","volume":"69","author":"Kysenius","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jlr.2023.100426_bib40","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/cyto.a.20346","article-title":"Proapoptotic effects of NARC 1 (= PCSK9), the gene encoding a novel serine proteinase","volume":"69","author":"Bingham","year":"2006","journal-title":"Cytometry A"},{"key":"10.1016\/j.jlr.2023.100426_bib41","first-page":"2098","article-title":"Inhibition of proprotein convertase subtilisin\/kexin type 9 attenuates neuronal apoptosis following focal cerebral ischemia via apolipoprotein E receptor 2 downregulation in hyperlipidemic mice","volume":"42","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jlr.2023.100426_bib42","first-page":"2787","article-title":"PCSK9 regulates apoptosis in human neuroglioma u251 cells via mitochondrial signaling pathways","volume":"8","author":"Piao","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.jlr.2023.100426_bib43","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1471-4159.2006.03928.x","article-title":"Implication of the proprotein convertase NARC-1\/PCSK9 in the development of the nervous system","volume":"98","author":"Poirier","year":"2006","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jlr.2023.100426_bib44","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1194\/jlr.M014118","article-title":"PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke","volume":"52","author":"Rousselet","year":"2011","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100426_bib45","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11745-014-3895-6","article-title":"PCSK9 is present in human cerebrospinal fluid and is maintained at remarkably constant concentrations throughout the course of the day","volume":"49","author":"Chen","year":"2014","journal-title":"Lipids"},{"key":"10.1016\/j.jlr.2023.100426_bib46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1515\/BC.2009.035","article-title":"Central nervous system: cholesterol turnover, brain development and neurodegeneration","volume":"390","author":"Dietschy","year":"2009","journal-title":"Biol. Chem."},{"key":"10.1016\/j.jlr.2023.100426_bib47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1471-4159.2009.05917.x","article-title":"Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats","volume":"109","author":"Nieweg","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jlr.2023.100426_bib48","article-title":"PCSK9 deficiency alters brain lipid composition without affecting brain development and function","volume":"15","author":"P\u00e4rn","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jlr.2023.100426_bib49","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1194\/jlr.M006635","article-title":"PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain","volume":"51","author":"Liu","year":"2010","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100426_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/srep17559","article-title":"Identification of PCSK9 as a novel serum biomarker for the prenatal diagnosis of neural tube defects using iTRAQ quantitative proteomics","volume":"5","author":"An","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2023.100426_bib51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/cga.12432","article-title":"A\u00a0comparison of the maternal levels of serum proprotein convertase subtilisin\/kexin type 9 in pregnant women with the complication of fetal open neural tube defects","volume":"61","author":"Erol","year":"2021","journal-title":"Congenit. Anom. (Kyoto)"},{"key":"10.1016\/j.jlr.2023.100426_bib52","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","article-title":"Brain cholesterol: long secret life behind a barrier","volume":"24","author":"Bj\u00f6rkhem","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2023.100426_bib53","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jsbmb.2018.12.009","article-title":"On the fluxes of side-chain oxidized oxysterols across blood-brain and blood-CSF barriers and origin of these steroids in CSF (Review)","volume":"188","author":"Bj\u00f6rkhem","year":"2019","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jlr.2023.100426_bib54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.devbrainres.2003.09.015","article-title":"Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse","volume":"146","author":"Quan","year":"2003","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.jlr.2023.100426_bib55","doi-asserted-by":"crossref","first-page":"8350","DOI":"10.1073\/pnas.0903541106","article-title":"Ablation of cholesterol biosynthesis in neural stem cells increases their VEGF expression and angiogenesis but causes neuron apoptosis","volume":"106","author":"Saito","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2023.100426_bib56","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41593-023-01288-6","article-title":"Lipid-accumulated reactive astrocytes promote disease progression in epilepsy","volume":"26","author":"Chen","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jlr.2023.100426_bib57","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tem.2013.10.003","article-title":"What are lipoproteins doing in the brain?","volume":"25","author":"Wang","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jlr.2023.100426_bib58","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/eurheartj\/ehy357","article-title":"PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor","volume":"40","author":"Da Dalt","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jlr.2023.100426_bib59","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.devcel.2023.01.002","article-title":"Characterization of the structure and control of the blood-nerve barrier identifies avenues for therapeutic delivery","volume":"58","author":"Malong","year":"2023","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jlr.2023.100426_bib60","doi-asserted-by":"crossref","first-page":"72","DOI":"10.14740\/jnr552","article-title":"Chronic inflammatory demyelinating Polyradiculoneuropathy association with low cholesterol levels: a case report in a patient taking PCSK9 inhibitor","volume":"9","author":"Franco","year":"2019","journal-title":"J.\u00a0Neurol. Res."},{"key":"10.1016\/j.jlr.2023.100426_bib61","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.clinthera.2022.03.013","article-title":"Lipids, lipid-lowering therapy, and neuropathy: a narrative review","volume":"44","author":"Pasha","year":"2022","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jlr.2023.100426_bib62","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1016\/j.atherosclerosis.2020.10.504","article-title":"Obesity related small fibre neuropathy is associated with circulating PCSK9","volume":"315","author":"Iqbal","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2023.100426_bib63","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1016\/j.atherosclerosis.2020.10.673","article-title":"PCSK9 monoclonal antibody treatment promotes small fibre regeneration in heterozygous familial hypercholesterolemia","volume":"315","author":"Soran","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2023.100426_bib64","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jacc.2016.11.037","article-title":"Safety of very low low-density lipoprotein cholesterol levels with alirocumab: pooled data from randomized trials","volume":"69","author":"Robinson","year":"2017","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2023.100426_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2015.09.004","article-title":"ApoER2 and Reelin are expressed in regenerating peripheral nerve and regulate Schwann cell migration by activating the Rac1 GEF protein, Tiam1","volume":"69","author":"Pasten","year":"2015","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.jlr.2023.100426_bib66","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.1523\/JNEUROSCI.3342-12.2013","article-title":"Schwann cell LRP1 regulates remak bundle ultrastructure and axonal interactions to prevent neuropathic pain","volume":"33","author":"Orita","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jlr.2023.100426_bib67","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/(SICI)1097-4547(20000215)59:4<581::AID-JNR14>3.0.CO;2-P","article-title":"Peripheral nerve regeneration and cholesterol reutilization are normal in the low-density lipoprotein receptor knockout mouse","volume":"59","author":"Goodrum","year":"2000","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.jlr.2023.100426_bib68","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0066-20.2020","article-title":"Peripheral nerve Single-cell analysis identifies Mesenchymal Ligands that promote axonal growth","volume":"7","author":"Toma","year":"2020","journal-title":"eNeuro"},{"key":"10.1016\/j.jlr.2023.100426_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001043","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) gene is a risk factor of large-vessel atherosclerosis stroke","volume":"2","author":"Abboud","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2023.100426_bib70","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.12659\/MSM.892091","article-title":"Correlation of PCSK9 gene polymorphism with cerebral ischemic stroke in Xinjiang han and uygur populations","volume":"20","author":"Han","year":"2014","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.jlr.2023.100426_bib71","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1161\/STROKEAHA.119.027759","article-title":"Stroke prevention with the PCSK9 (proprotein convertase subtilisin-kexin type 9) inhibitor evolocumab added to statin in high-risk patients with stable atherosclerosis","volume":"51","author":"Giugliano","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.jlr.2023.100426_bib72","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001632","article-title":"PCSK9 loss-of-function variants, low-density lipoprotein cholesterol, and risk of coronary heart disease and stroke: data from nine studies of African Americans and Whites","volume":"10","author":"Kent","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.jlr.2023.100426_bib73","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002162","article-title":"Large-Scale Phenome-wide association study of PCSK9 variants demonstrates protection against ischemic stroke","volume":"11","author":"Rao","year":"2018","journal-title":"Circ. Genom. Precis. Med."},{"key":"10.1016\/j.jlr.2023.100426_bib74","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1161\/STROKEAHA.114.005958","article-title":"Low levels of low-density lipoprotein-C associated with proprotein convertase subtilisin kexin 9 inhibition do not increase the risk of hemorrhagic transformation","volume":"45","author":"Tran-Dinh","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jlr.2023.100426_bib75","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1161\/STROKEAHA.113.001326","article-title":"Cholesterol levels and risk of hemorrhagic stroke","volume":"44","author":"Wang","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jlr.2023.100426_bib76","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.thromres.2022.03.021","article-title":"Pleiotropic effects of PCSK9-inhibition on hemostasis: anti-PCSK9 reduce FVIII levels by enhancing LRP1 expression","volume":"213","author":"Paciullo","year":"2022","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jlr.2023.100426_bib77","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/metabo12030226","article-title":"Pleiotropic effects of PCSK9: focus on thrombosis and haemostasis","volume":"12","author":"Puccini","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.jlr.2023.100426_bib78","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12944-022-01751-6","article-title":"PCSK9 inhibition and cholesterol homeostasis in insulin producing \u03b2-cells","volume":"21","author":"P\u00e4th","year":"2022","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jlr.2023.100426_bib79","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1161\/STROKEAHA.121.035677","article-title":"PCSK9 (proprotein convertase subtilisin kexin type 9) inhibition in hyperglycemic mice increases the risk of hemorrhagic transformation of ischemic stroke","volume":"52","author":"Nativel","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jlr.2023.100426_bib80","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1161\/STROKEAHA.120.030087","article-title":"Effects of inhibition or Deletion of PCSK9 (proprotein convertase subtilisin\/kexin type 9) on intracerebral hemorrhage volumes in mice","volume":"51","author":"Schlunk","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.jlr.2023.100426_bib81","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2023.100426_bib82","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","article-title":"Efficacy and safety of evolocumab in reducing lipids and cardiovascular events","volume":"372","author":"Sabatine","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2023.100426_bib83","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/eurheartj\/ehv563","article-title":"The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis","volume":"37","author":"Lipinski","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jlr.2023.100426_bib84","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(17)32290-0","article-title":"Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial","volume":"390","author":"Giugliano","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jlr.2023.100426_bib85","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2021.06.913","article-title":"Alirocumab treatment and neurocognitive function according to the CANTAB scale in patients at increased cardiovascular risk: a prospective, randomized, placebo-controlled study","volume":"331","author":"Janik","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2023.100426_bib86","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCULATIONAHA.117.029785","article-title":"PCSK9 variants, low-density lipoprotein cholesterol, and neurocognitive impairment: reasons for Geographic and Racial differences in stroke study (REGARDS)","volume":"137","author":"Mefford","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2023.100426_bib87","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002196","article-title":"Genetic assessment of potential long-Term on-target side effects of PCSK9 (proprotein convertase subtilisin\/kexin type 9) inhibitors","volume":"12","author":"Nelson","year":"2019","journal-title":"Circ. Genom. Precis. Med."},{"key":"10.1016\/j.jlr.2023.100426_bib88","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/ijnp\/pyy060","article-title":"Risk of neuropsychiatric adverse effects of lipid-lowering drugs: a mendelian randomization study","volume":"21","author":"Alghamdi","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jlr.2023.100426_bib89","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/embor.2008.132","article-title":"PCSK9 is required for the disposal of non-acetylated intermediates of the nascent membrane protein BACE1","volume":"9","author":"Jonas","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jlr.2023.100426_bib90","article-title":"Pretreatment with PCSK9 inhibitor protects the brain against cardiac ischemia\/reperfusion injury through a reduction of neuronal inflammation and amyloid beta aggregation","volume":"8","author":"Apaijai","year":"2019","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.jlr.2023.100426_bib91","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fnagi.2019.00120","article-title":"Proprotein convertase subtilisin\/kexin type 9, brain cholesterol homeostasis and potential implication for Alzheimer\u2019s disease","volume":"11","author":"Adorni","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jlr.2023.100426_bib92","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0304-3940(02)00942-4","article-title":"Low-density lipoprotein receptor-related protein 8 (apolipoprotein E receptor 2) gene polymorphisms in Alzheimer\u2019s disease","volume":"332","author":"Ma","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jlr.2023.100426_bib93","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1172\/JCI81108","article-title":"Endothelial LRP1 transports amyloid-\u03b2(1-42) across the blood-brain barrier","volume":"126","author":"Storck","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2023.100426_bib94","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00018-022-04237-x","article-title":"PCSK9 acts as a key regulator of A\u03b2 clearance across the blood-brain barrier","volume":"79","author":"Mazura","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jlr.2023.100426_bib95","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","article-title":"Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer\u2019s disease mice","volume":"28","author":"Hickman","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jlr.2023.100426_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012192","article-title":"PCSK9 affects astrocyte cholesterol metabolism and reduces neuron cholesterol supplying in\u00a0vitro: potential implications in Alzheimer\u2019s disease","volume":"23","author":"Papotti","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2023.100426_bib97","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1042\/CS20100094","article-title":"The vascular contribution to Alzheimer\u2019s disease","volume":"119","author":"Altman","year":"2010","journal-title":"Clin. Sci."},{"key":"10.1016\/j.jlr.2023.100426_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220254","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) in Alzheimer\u2019s disease: a genetic and proteomic multi-cohort study","volume":"14","author":"Picard","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2023.100426_bib99","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3233\/JAD-170993","article-title":"PCSK9 concentrations in cerebrospinal fluid are not specifically increased in Alzheimer\u2019s disease","volume":"62","author":"Courtemanche","year":"2018","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.jlr.2023.100426_bib100","doi-asserted-by":"crossref","first-page":"j1648","DOI":"10.1136\/bmj.j1648","article-title":"Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer\u2019s disease and Parkinson\u2019s disease: mendelian randomisation study","volume":"357","author":"Benn","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jlr.2023.100426_bib101","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/0891988718764330","article-title":"Loss-of-function PCSK9 mutations are not associated with Alzheimer disease","volume":"31","author":"Paquette","year":"2018","journal-title":"J.\u00a0Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.jlr.2023.100426_bib102","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25180-8","article-title":"Association between serum lipid levels over time and risk of Parkinson\u2019s disease","volume":"12","author":"Hurh","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2023.100426_bib103","doi-asserted-by":"crossref","first-page":"e1062","DOI":"10.1212\/WNL.0000000000201657","article-title":"Association between serum lipids and survival in patients with amyotrophic lateral sclerosis: a meta-analysis and population-based study","volume":"100","author":"Janse van Mantgem","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.jlr.2023.100426_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35232-7","article-title":"Lipoprotein markers associated with disability from multiple sclerosis","volume":"8","author":"Gafson","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2023.100426_bib105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacl.2009.11.003","article-title":"Altered cholesterol and fatty acid metabolism in Huntington disease","volume":"4","author":"Block","year":"2010","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.jlr.2023.100426_bib106","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12974-022-02409-x","article-title":"Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis","volume":"19","author":"Vigne","year":"2022","journal-title":"J.\u00a0Neuroinflammation"}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227523000998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227523000998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T18:32:49Z","timestamp":1758306769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227523000998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":106,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0022227523000998"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2023.100426","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCSK9 and the nervous system: a no-brainer?","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2023.100426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100426"}}